⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ds stage ii multiple myeloma

Every month we try and update this database with for ds stage ii multiple myeloma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantNCT00114101
DS Stage I Mult...
DS Stage II Mul...
DS Stage III Mu...
Refractory Mult...
Smoldering Mult...
Autologous Hema...
Laboratory Biom...
Lenalidomide
Melphalan
Peripheral Bloo...
Placebo Adminis...
18 Years - 70 YearsNational Cancer Institute (NCI)
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantNCT00114101
DS Stage I Mult...
DS Stage II Mul...
DS Stage III Mu...
Refractory Mult...
Smoldering Mult...
Autologous Hema...
Laboratory Biom...
Lenalidomide
Melphalan
Peripheral Bloo...
Placebo Adminis...
18 Years - 70 YearsNational Cancer Institute (NCI)
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple MyelomaNCT00098475
DS Stage I Mult...
DS Stage II Mul...
DS Stage III Mu...
Dexamethasone
Laboratory Biom...
Lenalidomide
Thalidomide
18 Years - National Cancer Institute (NCI)
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantNCT00114101
DS Stage I Mult...
DS Stage II Mul...
DS Stage III Mu...
Refractory Mult...
Smoldering Mult...
Autologous Hema...
Laboratory Biom...
Lenalidomide
Melphalan
Peripheral Bloo...
Placebo Adminis...
18 Years - 70 YearsNational Cancer Institute (NCI)
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple MyelomaNCT00644228
DS Stage I Mult...
DS Stage II Mul...
DS Stage III Mu...
Bortezomib
Dexamethasone
Laboratory Biom...
Lenalidomide
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: